ACM
ENTA icon

Aquatic Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Aquatic Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,510
Closed -$20.2K – 1349
2024
Q4 		$20.2K Sell
3,510
-490
-12% -$4.7K ﹤0.01% 1234
2024
Q3 		$41.4K Buy
+4,000
New +$52.3K ﹤0.01% 1015
2023
Q4 		– Sell
-1,100
Closed -$12K – 1407
2023
Q3 		$12K Buy
1,100
+500
+83% +$8.05K ﹤0.01% 1110
2023
Q2 		$13K Buy
+600
New +$17.7K ﹤0.01% 1170
2022
Q4 		– Sell
-6,100
Closed -$316K – 1486
2022
Q3 		$316K Buy
+6,100
New +$356K 0.03% 513

Other funds holding ENTA

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aquatic Capital Management's ENTA Position: Q1 2025 in Review

Aquatic Capital Management sold out of Enanta Pharmaceuticals (ENTA) in Q1 2025, closing a stake of 3,510 shares — an estimated $20.2K sold.

Aquatic Capital Management first reported a position in ENTA in Q3 2022 and held it in 5 quarters. The position peaked at $316K in Q3 2022. 109 funds tracked by Wall St. Rank hold ENTA as of Q1 2025.

  • Aquatic Capital Management reported no remaining Enanta Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 3,510 Enanta Pharmaceuticals shares in Q1 2025, an estimated $20.2K.
  • Aquatic Capital Management first reported a position in Enanta Pharmaceuticals in Q3 2022 and held it in 5 quarters.
  • Aquatic Capital Management's Enanta Pharmaceuticals position peaked at $316K in Q3 2022.
  • 109 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2025.

Based on Aquatic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.